Number of Shares
6,141.00
Current Holdings Value*
$81,120.00
% of Portfolio
1.45%
Total Estimate Gain
$-68,902.02
% of Total Estimate Gain
-86.91%

BlackRock U.S. Impact Fund's Pacific Biosciences of California Inc Holding Summary

As of 2023-07-31, BLACKROCK FUNDS held 6,141.00 shares of Pacific Biosciences of California Inc(PACB), totaling $81,120.00. This investment constitutes 1.45% of their stock portfolio, and BLACKROCK FUNDS now holds 0% of the outstanding Pacific Biosciences of California Inc(PACB) stock.

The initial trade took place in 2023Q3. And since then BlackRock U.S. Impact Fund has made 1 purchases of PACB, at an average price of $12.91, for a total of 6,141.00 shares. Based on historical transaction data and PACB's current price of $1.69, BlackRock U.S. Impact Fund's estimated gain on his PACB holdings is $-68,902.02, reflecting a -86.91% gain to date.

BlackRock U.S. Impact Fund PACB ($1.69) Holding Chart

BlackRock U.S. Impact Fund PACB ($1.69) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1